Everything tagged "biot" across research, earnings, and macro.
2 articles
Instinct Bio Technical Co. Holdings Inc. (BIOT) is expected to list on NASDAQ on 2026-07-24, but the price range has not been disclosed. This is a SPAC business combination, not a traditional underwritten IPO. The bull case is a vertically integrated regenerative medicine and stem-cell skincare platform; the bear case is that the public story is still light on disclosed financial detail.
Biotech Acquisition Company is expected to list on NASDAQ on 2026-07-24, but the price range has not been disclosed yet. This is a SPAC, so the real story is not current revenue — it is whether the sponsor can find and close a healthcare or biotech deal that the market will back. The setup favors target-selection upside, but shareholders should watch the trust structure, redemption risk, and the lack of operating business today.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator